PCA managing inadequate pain relief of patient controlled analgesia (adult)
If the patient's pain score is over 4 follow below:
We asked you in January to update to v4.7.2. After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.
To update to the latest release:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Welcome to the February 2025 update from the RDS team
A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:
The release will also incorporate a number of small fixes, including:
We will let you know when the date and time for the new release are confirmed.
There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.
The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.
Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.
At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .
We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.
Some important toolkits in development by the RDS team include:
The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.
To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)
To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form - also available in End-user and Provider sections of the RDS Learning and Support area. If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.
With kind regards
Right Decision Service team
Healthcare Improvement Scotland
Please note this guidance is for use in in-patients and is not designed for managing patients with chronic pain.
Patients with PCA must be nursed on a ward recognised by the Acute Pain Team and Department of Anaesthetics.
Within Raigmore Patient Controlled Analgesia may be used in:
A registered nurse caring for a patient with PCA should have attended the acute pain study and declare her/himself competent in the management of the PCA.
All PCA Infusion must be delivered via the Agilia PCA pump
Hospital SOPs on Preparation and Administration of Controlled Drugs (see resources) must always be adhered to.
The surgical medical staff or nurse practitioner should be called in the first instance for all routine surgical problems including:
If further advice is required, please contact the Acute Pain Nurse (bleep 1003) and if not available, the ITU anaesthetist.
All patients receiving PCA must have oxygen 4L/min by facemask or 2L/min via nasal cannula, for 24 hours postoperatively and then overnight until PCA is discontinued, unless directed to do so otherwise by an Anaesthetist.
NO OTHER OPIOIDS are to be administered to the patient whilst PCA is in use (oral, subcutaneous, intramuscular, intravenous or topical) unless directed to do so by an Anaesthetist or Acute Pain Nurse.
Ensure Naloxone 400 microgram injection is available on the ward.
PCA keys to be kept in the Controlled Drugs cupboard.
The standard prescription is Protocol A
The prescriber must complete a PCA chart, including the following details :
If a ward doctor or non-medical prescriber wishes to prescribe an alternative dose, discussion should first take place with the Acute Pain Nurse or an Anaesthetist.
Background infusions should only be used in patients who have been on long term opioids and must only be initiated by an Anaesthetist or Acute Pain Nurse.
The Prescription should be prescribed in the regular or 'As required' section of the Drug Kardex and affix a “PCA/Epidural Opioid in Progress” onto the Kardex.
Alternatives to Morphine may be used if required, please contact Acute Pain Nurse or ITU anaesthetist.
Anti-emetics must be prescribed on the Drug Kardex if patient is to have PCA, see TAM postoperative nausea and vomiting guidelines.
Preparation of each syringe must be witnessed by a trained nurse or doctor, in accordance with Hospital SOPs on Preparation and Administration of Controlled Drugs (see resources).
Change of syringe
Each change of syringe must be witnessed by a trained nurse or doctor who has received PCA training. Follow the Hospital SOPs on Preparation and Administration of Controlled Drugs (see resources).
Changing PCA extension sets
Patients with PCA need regular observations of pain, nausea, sedation and respiratory rate, in addition to the conventional postoperative recording.
Monitoring PCA Infusions
1. Pain score must be recorded on the observation chart
2. Sedation scores and respiration rate must be recorded on the observation chart
3. Nausea score must be recorded on the observation chart
NSAIDs and paracetamol help to minimise opioid side-effects by reducing the total dose of opioid required and should be prescribed regularly not PRN.
Moderate respiratory depression (respiratory rate less then 9 breaths per minute AND sedation score of 1 or 2)
Severe respiratory depression (respiratory rate less then 7 breaths per minute OR sedation score of 3.)
CALL FOR HELP, INITIATE CPR PROCEDURES, IF THE PATIENT IS APNOEIC, CALL 2222
Patient Controlled Analgesia should be discontinued when the patient no longer requires it, for example.
Note: Changing from PCA to subcutaneous injections is not acceptable when an oral route has been established. This may only be acceptable when intravenous access is difficult.
If a pump is broken or damaged in any way, please send to Medical Physics with a description of the fault.